Griffith University: Drug Typically Used for Opioid Addiction Could Be Long COVID Treatment
May 20, 2025
May 20, 2025
GOLD COAST, Australia, May 20 -- Griffith University issued the following news:
* * *
Drug typically used for opioid addiction could be Long COVID treatment
Low-dose naltrexone (LDN) has been identified as a potential treatment for Long COVID after a ground-breaking Griffith University study found it restored cellular function in human cells.
Long COVID affects millions of people worldwide with estimates suggesting more than 77 million people a . . .
* * *
Drug typically used for opioid addiction could be Long COVID treatment
Low-dose naltrexone (LDN) has been identified as a potential treatment for Long COVID after a ground-breaking Griffith University study found it restored cellular function in human cells.
Long COVID affects millions of people worldwide with estimates suggesting more than 77 million people a . . .